Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Med Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced the ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

While every medical specialty faces challenges, the emergency department presents a distinct set of pressures: unpredictable ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...

Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...